
Results-driven Manager in CMC Regulatory Affairs with proven success in regulatory strategy development and FDA compliance. Expertise in change control management and cross-functional collaboration to support efficient product launches.
· Led analysis of drug products, focusing on controlled and delayed release formulations for regulated markets such as the US and Europe under cGLP conditions.
· Performed several pharmacopeial tests, such as Dissolution, Assay, Related Substance (RS), Uniformity of Dosage (UOD) study of Tablets, and Capsules.
· Compiled and mapped dissolution profiles of innovator and in-house products with varying drug-release patterns according to standard test procedures.
· Operated HPLC instruments utilizing multiple detector types, including VWD, MWD, PDA, and fluorescence, ensuring accurate analytical results.
· Performed cleaning validation of production equipment.
Completed training on GLP, GCP, and GMP quality system modules to ensure compliance with industry standards.